Candel Therapeutics, Inc. Revenue 2020-2022 | CADL - Developers Digest

← All companies

C

Candel Therapeutics, Inc.

CADL - CIK 0001841387

Market cap-

Rank-

SEC filings382

Candel Therapeutics, Inc. revenue by year

Candel Therapeutics, Inc. (CADL) reported revenue of $125.00K for fiscal year 2022, as filed in its audited annual report with the SEC.

CADL annual revenue

CADL revenue 2020-2022

Fiscal year	Revenue	Change
FY 2022	$125.00K	+0.0%
FY 2021	$125.00K	+0.0%
FY 2020	$125.00K	-

Revenue of similar companies

AMGNAmgen Inc.$191.09 B GILDGilead Sciences, Inc.$156.28 B ARGXargenx SE$55.63 B RVMDRevolution Medicines, Inc.$31.73 B BIIBBiogen Inc.$29.52 B BNTXBioNTech SE$22.64 B

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.